41. P490: SNORNA-DERIVED RNAS (SDRNAS) ARE IMPORTANT DRIVERS OF LEUKEMOGENESIS AND LEUKEMIC MAINTENANCE IN AML. (23rd June 2022) Authors: Zinz, R.; Rohde, C.; Heid, D.; Bruckmann, M.; Bornhäuser, M.; Röllig, C.; Platzbecker, U.; Baldus, C.; Serve, H.; Zhou, F.; Pabst, C.; Müller-Tidow, C.; Blank, M. F. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 389 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
42. P509: CLONAL HEMATOPOIESIS-ASSOCIATED MUTATIONS AS MEASURABLE RESIDUAL DISEASE MARKERS IN ACUTE MYELOID LEUKEMIA PATIENTS FOLLOWING ALLOGENEIC STEM CELL TRANSPLANTATION. (23rd June 2022) Authors: Bischof, L.; Ussmann, J.; Brauer, D.; Backhaus, D.; Herrmann, L.; Franke, G.-N.; Vucinic, V.; Metzeler, K. H.; Platzbecker, U.; Schwind, S.; Jentzsch, M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 408 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
43. P529: FIRST EUROPEAN REAL-WORLD EVIDENCE PROSPECTIVE REGISTRY OF FIRST-LINE ADULT PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM TREATED WITH FIRST-IN-CLASS CD123-TARGETED THERAPY TAGRAXOFUSP. (23rd June 2022) Authors: Platzbecker, U.; Angelucci, E.; Montesinos, P.; Lemoli, R. M.; Spyridonidis, A.; Casariego, J.; Mughal, T. I.; Mohty, M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 428 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
44. P545: CHARACTERISTICS AND OUTCOME OF PATIENTS WITH ACUTE MYELOID LEUKEMIA AND TRISOMY 19. (23rd June 2022) Authors: Kayser, S.; Martínez-Cuadrón, D.; Rodriguez-Veiga, R.; Hänel, M.; Tormo, M.; Schäfer-Eckart, K.; Botella, C.; Stölzel, F.; Bernal del Castillo, T.; Keller, U.; Rodriguez-Medina, C.; Held, G.; Amigo, M.-L.; Schliemann, C.; Colorado, M.; Kaufmann, M.; Barrios Garcia, M.; Krause, S. W.; Görner, M.; ... Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 444 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
45. P561: VIALE-T: A RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY OF VENETOCLAX IN COMBINATION WITH AZACITIDINE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOID LEUKEMIA. (23rd June 2022) Authors: Craddock, C.; Platzbecker, U.; Heuser, M.; Pullarkat, V.; Chaudhury, S.; Wu, D.; Addo, S.; Chyla, B.; Jiang, Q.; Lee, P.; Wolff, J. E. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 460 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
46. P573: PHARMACOKINETIC EXPOSURE EQUIVALENCE AND PRELIMINARY EFFICACY AND SAFETY FROM A RANDOMIZED CROSS OVER PHASE 3 STUDY OF AN ORAL HYPOMETHYLATING AGENT DEC-C COMPARED TO IV DECITABINE IN AML PATIENTS. (23rd June 2022) Authors: Geissler, K.; Koristek, Z.; Bernal del Castillo, T.; Novák, J.; Rodriguez Macias, G.; Metzelder, S. K.; Illes, A.; Nagy, A.; Mayer, J.; Arnan, M.; Keating, M.-M.; Krauter, J.; Lunghi, M.; Stefano Fracchiolla, N.; Platzbecker, U.; Santini, V.; Sano, Y.; Oganesian, A.; Keer, H.; Lübbert, M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 472 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
47. P724: THE BONE MARROW MESENCHYMAL CELL-DERIVED EXTRACELLULAR MATRIX IS SIGNIFICANTLY ALTERED IN PATIENTS WITH MELODYSPLASTIC SYNDROMES. (23rd June 2022) Authors: Bains, A.; Behrens Wu, L.; Richter, M.; Magno, V.; Rother, S.; Cross, M.; Werner, C.; Wobus, M.; Platzbecker, U. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 619 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
48. P747: LR-MDS IS CHARACTERIZED BY DIFFERENTIAL EXPRESSION OF INFLAMMASOME-RELATED GENES IN SPECIFIC CELL POPULATIONS. (23rd June 2022) Authors: Rolfs, C.; Schneider, M.; Trumpp, M.; Fischer, L.; Winter, S.; Uxa, S.; Menger, V.; Nenoff, K.; Kubasch, A. S.; Metzeler, K.; Sockel, K.; Thiede, C.; Hofbauer, L.; Brüderle, A.; Woo, J.; Cross, M.; Platzbecker, U. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 642 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
49. P752: TARGETING S100A9 IN THE MYELODYSPLASTIC INFLAMMATORY BONE MARROW MICROENVIRONMENT BY TASQUINIMOD IMPROVES THE SUPPORTIVE FUNCTION OF MESENCHYMAL STROMAL CELLS. (23rd June 2022) Authors: Wobus, M.; Balaian, E.; Lissner, M.; Towers, R.; Oelschlägel, U.; Wehner, R.; Chavakis, T.; Törngren, M.; Eriksson, H.; Bondesson, E.; Platzbecker, U.; Bornhäuser, M.; Sockel, K. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 647 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
50. P778: LONG-TERM UTILIZATION AND BENEFIT OF LUSPATERCEPT IN PATIENTS (PTS) WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) FROM THE MEDALIST TRIAL. (23rd June 2022) Authors: Fenaux, P.; Santini, V.; Komrokji, R. S.; Zeidan, A.; Garcia-Manero, G.; Buckstein, R.; Miteva, D.; Keeperman, K.; Holot, N.; Zhang, J.; Nadal, J. A.; Rosettani, B.; Yucel, A.; Platzbecker, U. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 673 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗